Bulk billing benefits for all Australian General Practices
Bulk billing benefits for all Australian General Practices
From 1 November 2025 every general practice will benefit from expanded eligibility for MBS bulk billing incentives to all Australians with a Medicare card.
The expanded eligibility of the existing MBS bulk billing incentive to all Australians means that current bulk billing incentives payable to practices that bulk bill children under 16 years of age and patients with a Commonwealth concession card will expand to include all Australians with a Medicare card.
Additionally, from 1 November practices will be able to choose if they wish to participate in the new bulk billing practice incentive program.
New information on both of these bulk billing measures is now available on the Department of Health and Aged Care website including frequently asked questions, and details on eligible MBS services.
Information about the new Bulk Billing Practice Incentive Program
Practices participating in the new Bulk Billing Practice Incentive Program (the Program) will receive an additional 12.5% incentive payment on every $1 of MBS benefit earned from eligible services, split between the GP and the practice.
Participating practices must bulk bill every eligible service for every patient, to receive the incentive payment. This incentive payment will be in addition to MBS Benefits paid (including bulk billing incentives).
To participate in the Program, practices will need to:
Bulk bill all eligible services
Advertise their participation in the Program
Be MyMedicare registered (note that practices that are not already MyMedicare registered and wish to participate in the Program will be exempt from MyMedicare accreditation requirements).
To register in the Program, practices will need to:
register to participate in MyMedicare
register to participate in the Program via MyMedicare.
General Practices can register to participate in the Program from 1 November 2025.
For further general support on MyMedicare or the General Practice Aged Care Incentive (GPACI), please contact CESPHNs Practice Support Team at practicesupport@cesphn.com.au
Eora Health Messenger Winter 2025 EORA Health Messenger Winter 2025 edition is live now. This quarterly edition covers the following topics: Celebrating connection Winter events to enjoy Community engagement opportunities Reflections on seasonal change Latest local news and updates
Immunisation Weekly Update: Cessation of MBS COVID-19 vaccine support items from 1 July 2025 2025 updates to anaphylaxis training RSV vaccine safety data and resources New NCIRS meningococcal vaccines FAQs resource Influenza vaccination coverage data update Changes to pharmacist vaccination programs Education Cessation of MBS COVID-19 vaccine support items from…
Immunisation Weekly Update: Stay up to date with measles Protecting your patients from the flu First clade 1b mpox case in Australia Remind your patients about RSV and maternal vaccinations in pregnancy New First Nations and childhood vaccination resources Stay up to date with measles Lunch and learn recording and…
Immunisation Weekly Update: Federal ministers and national media react to falling vaccination rates Be mindful of measles before and after Hajj COVID-19 vaccine update and new resource Flu Vaccine Updates ‘Possible but rare’ RSV vaccine risk First Nations maternal vaccinations poster Federal ministers and national media react to falling vaccination…
Immunisation Weekly Update: CESPHN seeking Immunisation Working Group clinical representatives Lunch and Learn: Measles awareness and prevention in 2025 Concerns rise as vaccination rates continue to fall The latest influenza vaccination coverage data Access to existing Q Fever statements in the Q Fever Register to end 30 June 2025 Have…
Immunisation Weekly Update: Lunch and Learn: Measles awareness and prevention in 2025 Australia on track for record number of flu cases Free SMS recall – 2025 Quality Improvement programs Large-scale revamp of Handbook immunocompromised chapter In case you missed it… Beyfortus™ (nirsevimab) eligibility expansion Access to the Australian Immunisation Register…